|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Merck & Co., Inc. - SWOT Analysis
|
| Published Date:
May 2009
Published By:
Datamonitor
Page Count:
29
Order Code:
R313-51414
|
|
|
|
Datamonitor's Merck & Co. - SWOT Analysis company profile is the essential source for top-level company data and information. Merck & Co. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Merck & Co. is a global pharmaceutical company engaged in research, manufacturing and marketing of drugs and pharmaceuticals. The company’s products include therapeutic and preventive agents, and vaccines generally sold by prescription for the treatment of human disorders and animal health supplies. Merck & Co. is headquartered in Whitehouse Station, New Jersey and employs 59,800 people. The company recorded revenues of $24,197.7 million during the financial year (FY) ended December 2007, an increase of 6.9% over 2006. The operating profit of the company was $3,370.7 million during FY2007, a decrease of 45.8% over 2006. The net profit was $3,275.4 million in FY2007, a decrease of 26.1% over 2006.
Scope of the Report- Provides all the crucial information on Merck & Co. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Merck & Co. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Merck & Co.
- Data is supplemented with details on Merck & Co. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Merck & Co.
Reasons to Purchase- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Snapshots Poland Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Venezuela Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Spain Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots South Africa Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Hungary Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
|
|
|
|
0 items
